| Index | — | P/E | 22.73 | EPS (ttm) | 8.89 | Insider Own | 16.53% | Shs Outstand | 15.66M | Perf Week | -9.66% |
| Market Cap | 3.17B | Forward P/E | — | EPS next Y | — | Insider Trans | -1.57% | Shs Float | 12.71M | Perf Month | -11.23% |
| Enterprise Value | 2.91B | PEG | — | EPS next Q | — | Short Float | 5.94% | Perf Quarter | -2.93% | ||
| Income | 140.00M | P/S | 2.03 | EPS this Y | — | Short Ratio | 7.21 | Perf Half Y | 18.45% | ||
| Sales | 1.56B | P/B | 2.81 | EPS next Y | — | ROA | 9.13% | Short Interest | 755.04K | Perf YTD | 47.41% |
| Book/sh | 72.02 | P/C | 11.90 | EPS next 5Y | — | ROE | 12.94% | 52W High | 248.20 -18.58% | Perf Year | 65.93% |
| Cash/sh | 16.98 | P/FCF | 21.68 | EPS past 3/5Y | 74.24% 23.04% | ROIC | 7.25% | 52W Low | 118.14 71.06% | Perf 3Y | 203.21% |
| Dividend Est. | 2.68 (1.33%) | EV/EBITDA | 12.44 | Sales past 3/5Y | 12.22% 9.12% | Gross Margin | 39.49% | Volatility | 4.41% 3.60% | Perf 5Y | 184.19% |
| Dividend TTM | 2.62 (1.30%) | EV/Sales | 1.87 | EPS Y/Y TTM | 32.49% | Oper. Margin | 9.28% | ATR (14) | 8.41 | Perf 10Y | 209.95% |
| Dividend Ex-Date | Sep 30, 2026 | Quick Ratio | 22.06 | Sales Y/Y TTM | 7.00% | Profit Margin | 9.00% | RSI (14) | 33.10 | Recom | — |
| Dividend Gr. 3/5Y | 3.83% 3.99% | Current Ratio | 22.06 | EPS Q/Q | 53.94% | SMA20 | -11.27% | Beta | 0.64 | Target Price | — |
| Payout | 28.36% | Debt/Eq | 0.01 | Sales Q/Q | 8.80% | SMA50 | -10.32% | Rel Volume | 1.40 | Prev Close | 206.14 |
| Employees | 15,278 | LT Debt/Eq | 0.01 | Earnings | Nov 06 | SMA200 | 3.95% | Avg Volume | 117.94K | Price | 202.09 |
| IPO Date | Jan 02, 1987 | Option/Short | Yes / Yes | EPS/Sales Surpr. | — | Net Debt/EBITDA | -1.08 | Volume | 165,065 | Change | -1.96% |
National HealthCare Corporation (NHC) is a prominent provider in the healthcare sector, involved in the operation, management, and service provision for a wide array of elder care and health facilities. Its diverse portfolio includes skilled nursing facilities, assisted living communities, independent living residences, homecare and hospice agencies, and a specialized behavioral health hospital. Within its skilled nursing environments, NHC offers extensive therapeutic and medical care. Patients recovering from conditions such as strokes, heart attacks, orthopedic injuries, neurological ailments, or other illnesses and disabilities benefit from licensed physical, speech, respiratory, and occupational therapies. These facilities also provide essential services like nutritional guidance, social support, recreational activities, and daily necessities such as housekeeping and laundry, all complemented by physician-prescribed medical treatments. Distinctive medical specialty units further enhance care, featuring memory care for individuals with Alzheimer's and similar disorders, alongside sub-acute nursing units. NHC's assisted living centers are designed to offer personal support, helping residents with everyday tasks including dressing, bathing, meal preparation, and medication management. The company also addresses mental well-being through behavioral health services for both adults and geriatric patients, treating psychiatric, emotional, and addictive conditions. Beyond direct facility care, NHC delivers additional healthcare programs, incorporating skilled services like infusion, wound care, and advanced physical, occupational, and speech therapies. Its offerings extend to hospice care, the operation of pharmacies, and a suite of corporate services encompassing management, accounting, financial, and insurance solutions. Furthermore, NHC engages in leasing its properties to third-party operators. As of February 18, 2022, NHC's operational footprint was substantial, comprising 75 skilled nursing facilities with a capacity of 9,473 beds, 24 assisted living facilities, 5 independent living facilities, one behavioral health hospital, 34 homecare agencies, and 28 hospice agencies. Founded in 1971, National HealthCare Corporation is headquartered in Murfreesboro, Tennessee.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,560 | 1,518 | 1,298 | 1,142 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 943 | 921 | 811 | 712 | — | — | — | — | — | |
| Gross Profit | 615 | 597 | 487 | 429 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 47 | 46 | 43 | 42 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 423 | 422 | 358 | 330 | — | — | — | — | — | |
| Operating Income | 144 | 128 | 86 | 57 | — | — | — | — | — | |
| Interest Expense | 2 | 6 | 4 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 43 | 40 | 55 | 32 | — | — | — | — | — | |
| Net Income Before Taxes | 185 | 162 | 136 | 89 | — | — | — | — | — | |
| Income Taxes | 42 | 40 | 34 | 23 | — | — | — | — | — | |
| Consolidated Net Income | 140 | 120 | 102 | 67 | — | — | — | — | — | |
| Net Income From Continuing Operations | 143 | 123 | 102 | 65 | — | — | — | — | — | |
| Net Income | 140 | 120 | 102 | 67 | — | — | — | — | — | |
| EPS (Recurring) | 9.03 | 7.76 | 6.62 | 4.36 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 9.03 | 7.76 | 6.62 | 4.36 | — | — | — | — | — | |
| EPS (Diluted) | 8.89 | 7.67 | 6.53 | 4.34 | — | — | — | — | — | |
| EBITDA | 234 | 214 | 183 | 131 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 22.73 | 17.87 | 16.47 | 21.29 | — | — | — | — | — | |
| Price To Sales Ratio | 2.07 | 1.35 | 1.24 | 1.21 | — | — | — | — | — | |
| Gross Margin | 39.42 | 39.33 | 37.52 | 37.57 | — | — | — | — | — | |
| Operating Margin | 9.23 | 8.43 | 6.63 | 4.99 | — | — | — | — | — | |
| Net Margin | 8.97 | 7.91 | 7.86 | 5.87 | — | — | — | — | — | |
| Shares Outstanding | 16 | 15 | 15 | 15 | — | — | — | — | — | |
| Market Capitalization | 3,233 | 2,056 | 1,613 | 1,386 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Dodson Vicki L | Sr.VP Patient Srvcs | Sep 22 '26 | Sale | 225.00 | 4,834 | 1,087,650 | 10,726 | Sep 23 |
| KIDD BRIAN F | SVP, CFO | Sep 11 '26 | Sale | 225.70 | 6,813 | 1,537,694 | 23,183 | Sep 14 |
| McCreary Josh A | Senior VP & General Counsel | Sep 10 '26 | Sale | 224.23 | 2,719 | 609,669 | 9,979 | Sep 14 |
| FLATT BEN ANDERSON SR | Senior VP & CIO | Aug 28 '26 | Sale | 222.50 | 1,000 | 222,500 | 15,636 | Sep 02 |
| FLATT BEN ANDERSON SR | Senior VP & CIO | Aug 25 '26 | Sale | 227.00 | 1,000 | 227,000 | 16,636 | Sep 02 |
| FLATT BEN ANDERSON SR | Senior VP & CIO | Aug 20 '26 | Sale | 237.00 | 1,000 | 237,000 | 17,636 | Sep 02 |
| FLATT BEN ANDERSON SR | Senior VP & CIO | Aug 19 '26 | Sale | 237.18 | 1,000 | 237,180 | 18,636 | Sep 02 |
| FLATT BEN ANDERSON SR | Senior VP & CIO | Aug 17 '26 | Sale | 226.00 | 1,000 | 226,000 | 19,636 | Sep 02 |
| FLATT BEN ANDERSON SR | Senior VP & CIO | Aug 14 '26 | Sale | 222.11 | 1,000 | 222,110 | 20,636 | Sep 02 |
| FLATT BEN ANDERSON SR | Senior VP & CIO | Aug 12 '26 | Sale | 221.21 | 1,000 | 221,210 | 21,636 | Sep 02 |
| Gifford David R. | Director | Aug 25 '26 | Sale | 225.42 | 1,779 | 401,022 | 1,030 | Aug 28 |
| Gifford David R. | Director | Aug 20 '26 | Option Exercise | 171.42 | 6,479 | 1,110,630 | 7,500 | Aug 21 |
| Flatt Stephen Fowler | CEO | Aug 19 '26 | Sale | 237.08 | 1,500 | 355,620 | 65,487 | Aug 20 |
| Gifford David R. | Director | Aug 13 '26 | Option Exercise | 171.42 | 1,021 | 175,020 | 1,021 | Aug 17 |
| HASSAN EMIL E | Director | Jun 22 '26 | Sale | 200.00 | 5,937 | 1,187,400 | 65,595 | Jun 23 |